Diseases, Conditions, Syndromes

Efpeglenatide lowers risk for adverse CV events in T2DM

(HealthDay)—For patients with type 2 diabetes and a history of cardiovascular disease or current kidney disease, the risk for adverse cardiovascular events is lower with efpeglenatide, an exendin-based glucagon-like peptide ...

Obstetrics & gynaecology

Higher-dose DHA in pregnancy tied to fewer early preterm births

(HealthDay)—Supplementation with a higher dose of docosahexaenoic acid (DHA) versus the standard prenatal dose during the second half of pregnancy is associated with a lower rate of early preterm births, according to a ...

Health

USPSTF affirms evidence-based methods for smoking cessation

The U.S. Preventive Services Task Force (USPSTF) concludes that there is substantial net benefit for behavioral and pharmacological therapies for smoking cessation, alone or combined. These findings form the basis of a final ...

Oncology & Cancer

FDA authorizes marketing of EndoRotor system

The U.S. Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis ...

page 7 from 21